.png)
Chronic Lyme Disease and Co-Infections
Led by Dr. Michael Scoma, a board-certified infectious disease specialist, we provide precision-based care for chronic Lyme disease and complex tick-borne co-infections, utilizing advanced diagnostics and targeted oral and intravenous therapies to address persistent infection, immune dysregulation, and neuroinflammation—focused on long-term restoration and improved quality of life.
Specialized expertise in the comprehensive evaluation, diagnosis, and management of complex, treatment-resistant Lyme disease syndromes and associated tick-borne co-infections; Babesia, Bartonella, Ehrlichia, and Anaplasma.
Advanced diagnostic methodology utilizing state-of-the-art serologic, molecular, and immunologic testing platforms to differentiate between acute, latent, and persistent infection states with a high degree of clinical accuracy.
Targeted therapeutic protocols that integrate oral and intravenous antimicrobial regimens, biofilm-disruptive strategies, and adjunctive therapies directed at bacterial persister forms and immune-evasive mechanisms.
Neuromodulatory and immunoregulatory therapies tailored to address neuroinflammatory, cognitive, and autonomic nervous system involvement, while rebalancing immune function and reducing systemic inflammatory burden.
A precision-based, highly individualized care model that combines evidence-informed medicine with functional restoration, focusing on long-term physiologic healing, immune system optimization, and improved quality of life.
ILADS member, evidence-based clinical framework, grounded in International Lyme and Associated Disease Society guidelines.
